BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation

CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...

August 22, 2023 | News

Hummingbird Bioscience to Present HMBD-001 Combo Strategy for Lung Cancer at 2023 Conference

The poster will highlight the scientific rationale for combining anti-HER3 antibody HMBD-001 with EGFR inhibition and chemotherapy to improve treatment out...

August 22, 2023 | News

Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy

"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...

August 22, 2023 | Regulatory

FOXO Technologies™ and DataRobot Partner for AI-Driven Human Longevity Research

Epigenetic biomarkers provide valuable insights into the relationships among health, aging, and human longevity. These biomarkers are developed by leveragi...

August 19, 2023 | News

3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling

3Z, holds expertise in developing genetically engineered models of central nervous system disorders, has successfully identified potential ADHD treatments ...

August 19, 2023 | News

Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed

Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...

August 18, 2023 | News

MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems

MGI, a company committed to building core tools and technology to lead life science, today announced the global launch of MGISP-NEX and MGIFLP-L50 automati...

August 17, 2023 | News

CytoMed Collaborates for Improved Allogeneic CAR γδ T In Vivo Persistence in China

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its propr...

August 16, 2023 | News

OnCusp Therapeutics Gets FDA Nod for Phase 1 Trial of CUSP06 in Ovarian & Solid Tumors

"We are delighted to announce the IND approval for our flagship program, CUSP06, which has demonstrated excellent anti-tumor efficacy across diverse in&nbs...

August 16, 2023 | News

Thermo Fisher Scientific Completes Acquisition of CorEvitas

Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Sh...

August 15, 2023 | News

HebeCell & Logomix Partner for Next Gen PSC-NK Cell Development

Under the agreement, the companies enter a strategic partnership where Logomix first provides genome editing capabilities to HebeCell for development of ne...

August 15, 2023 | News

Neurophth Raises Almost $95M for Gene Therapy Trials in Series C+ Funding

Additionally, several prominent investment firms participated, including CMG-SDIC Capital, Silicon Paradise Asset Management and Yangtze River Industry Fun...

August 14, 2023 | News

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody discovery, lead ...

August 11, 2023 | News

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) ha...

August 11, 2023 | News

Stay Connected